Related references
Note: Only part of the references are listed.CD4+CD25+High Foxp3+ Regulatory T Cells, B Lymphocytes, and T Lymphocytes in Patients With Acute ITP in Assiut Children Hospital
Asmaa M. Zahran et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2014)
Quantitative and functional analyses of CD4+CD25+FoxP3+ regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylate
Emmanuel Bachy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Evaluation of monocyte-derived dendritic cells, T regulatory and Th17 cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
Iwona Hus et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2011)
CD4+CD25highFoxP3+ Regulatory T-cells in Hematologic Diseases
Hee-Won Moon et al.
KOREAN JOURNAL OF LABORATORY MEDICINE (2011)
Naturally occurring CD4+ CD25+ FOXP3+ T-regulatory cells are increased in chronic myeloid leukemia patients not in complete cytogenetic remission and can be immunosuppressive
Jose M. Rojas et al.
EXPERIMENTAL HEMATOLOGY (2010)
Reduced circulating CD4(+)CD25(+) cell populations in haemorrhagic fever with renal syndrome
L. Y. Zhu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Regulatory T Cells: Major Players in the Tumor Microenvironment
Marc Beyer et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
Roberto Stasi et al.
BLOOD (2008)
Regulatory T cells and treatment of cancer
Tyler J. Curiel
CURRENT OPINION IN IMMUNOLOGY (2008)
Imatinib Mesylate Inhibits CD4+CD25+ Regulatory T Cell Activity and Enhances Active Immunotherapy against BCR-ABL- Tumors
Nicolas Larmonier et al.
JOURNAL OF IMMUNOLOGY (2008)
MYB function in normal and cancer cells
Robert G. Ramsay et al.
NATURE REVIEWS CANCER (2008)
How I treat chronic myeloid leukemia in the imatinib era
John M. Goldman
BLOOD (2007)
Increased frequencies of CD4(+)CD25(high) T-regs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
E. Nadal et al.
LEUKEMIA (2007)
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease
Shimon Sakaguchi et al.
IMMUNOLOGICAL REVIEWS (2006)
Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation
Nicolas Boissel et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma
GC Cesana et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
NA Marshall et al.
BLOOD (2004)
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells
S Appel et al.
BLOOD (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies -: Possible involvement of regulatory T cells in disease progression
T Sasada et al.
CANCER (2003)
The effects of STI571 on antigen presentation of dendritic cells generated from patients with chronic myelogenous leukemia
N Sato et al.
HEMATOLOGICAL ONCOLOGY (2003)
An essential role for Scurfin in CD4+CD25+ T regulatory cells
R Khattri et al.
NATURE IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
